Christina Kay

2022

In 2022, Christina Kay earned a total compensation of $276.3K as Co, Chief Executive Officer at Integrated Biopharma, a 12% increase compared to previous year.

Compensation breakdown

Option Awards$39,151
Salary$228,398
Other$8,702
Total$276,251

Kay received $228.4K in salary, accounting for 83% of the total pay in 2022.

Kay also received $39.2K in option awards and $8.7K in other compensation.

Rankings

In 2022, Christina Kay's compensation ranked 5,161st out of 5,756 executives tracked by ExecPay. In other words, Kay earned more than 10.3% of executives.

ClassificationRankingPercentile
All
5,161
out of 5,756
10th
Division
Manufacturing
2,835
out of 3,133
10th
Major group
Chemicals And Allied Products
1,319
out of 1,419
7th
Industry group
Drugs
1,240
out of 1,320
6th
Industry
Pharmaceutical Preparations
905
out of 966
6th
Source: SEC filing on October 27, 2022.

Kay's colleagues

We found four more compensation records of executives who worked with Christina Kay at Integrated Biopharma in 2022.

2022

Dina Masi

Integrated Biopharma

Chief Financial Officer

2022

E Kay

Integrated Biopharma

Chairman

2022

EGerald Kay

Integrated Biopharma

Chairman

2022

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

News

You may also like